Roivant Sciences reported positive Phase 2 results for its experimental lung disease drug, Mosliciguat, while Pharvaris’ oral ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech stocks Roivant and Pharvaris hit records Tuesday on "blowout" and "bull case" results for lung and swelling disease ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% ...

In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now. Following a turbulent year for the markets in general and biotech in particular, the industry made a notable ...

Incyte (INCY) stock is trading just below a buy zone just as Big Money is giving it the stamp of approval. Shares popped in ...

Biotechnology investing is a strange corner of the market. A company can own a drug that may eventually produce billions of ...

The drugmaker should significantly mitigate its most important risk as it develops new products.

Biotechnology stocks represent a great opportunity for investors who are fortunate enough to get into the right names at the right time. The biotech stock sector has always been a stellar performer in ...

Gaps are information. They are the place on the chart where you can see buyers and sellers jumping ahead to a fast repricing, usually in response to company-specific news that suddenly and ...

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...